drugset / Trial / NCT04939116
Study of Safety and Efficacy of ANG-3070 in Chronic Kidney Disease
RandomizedParallel-groupTriple-blindTreatment
Summary
The major objective is to demonstrate the safety and efficacy of ANG-3070 in patients with primary glomerular disease and persistent proteinuria.
Timeline
- Start
- 2021-12-24
- Primary completion
- 2023-07-31
- Completion
- 2023-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ANG-3070 | Unknown | 200 mg | Oral |
| Subject | ANG-3070 | Unknown | 300 mg | Oral |
| Subject | ANG-3070 | Unknown | 400 mg | Oral |